CryoBalloon Ablation for Treatment of Duodenal Adenomas
NCT: NCT03847636 · COMPLETED
Brief Summary
This multicenter prospective non-randomized interventional study (clinical trial) that will assess the safety and efficacy of cryoballoon ablation treatment using the C2 Cryoballoon device (Pentax Medical Corporation) as an alternative primary treatment modality for sporadic and familial nonampullary nonpolypoid (flat) duodenal adenomas.
Frequently Asked Questions
What is CryoBalloon Ablation for Treatment of Duodenal Adenomas?
CryoBalloon Ablation for Treatment of Duodenal Adenomas is a clinical trial registered under NCT03847636. Current status: COMPLETED.
What is the status of NCT03847636?
The current status of NCT03847636 (CryoBalloon Ablation for Treatment of Duodenal Adenomas) is: COMPLETED.
When did CryoBalloon Ablation for Treatment of Duodenal Adenomas start?
CryoBalloon Ablation for Treatment of Duodenal Adenomas started on 2019-05-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.